 Inclusion Criteria: - Symptomatic CHF despite optimized therapy for at least the previous 3 months treatment included a diuretic, angiotensin converting enzyme ACE inhibitor, andor an A2 antagonist, unless not tolerated - Hemoglobin greater than or equal to 12.5 gdL at the time of screening 